Trajenta is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes Normally after you eat your pancreas releases insulin to help your body store excess sugar for later use This process occurs during normal digestion of food In type 2 diabetes your body does not work properly to store excess sugar and the sugar remains in your blood Chronic high blood sugar can lead to serious health problems in the future Proper diet is the first step in managing type 2 diabetes but often medicines are needed to help your body Trajenta helps to control blood sugar levels by increasing substances in the body that make the pancreas release more insulin It also signals the liver to stop producing sugar glucose when there is too much sugar in the blood Trajenta does not help patients who have insulin dependent or type 1 diabetes because they do not produce insulin from the pancreas The high blood sugar is best controlled with insulin Injections in these patients Trajenta is available only with your doctor s prescription

Trajenta 5 mg Tablet 10 s should not be taken if you are allergic to Trajenta 5 mg Tablet 10 s or any of its ingredients Please inform your doctor if you are pregnant or breastfeeding before starting Trajenta 5 mg Tablet 10 s Prolonged intake of Trajenta 5 mg Tablet 10 s may cause acute pancreatitis swollen pancreas and critical kidney problem Increased risk of hypoglycaemia low blood sugar level can occur when Trajenta 5 mg Tablet 10 s is added to other anti diabetic agents or insulin therapy In this case your doctor may adjust the dose of Trajenta 5 mg Tablet 10 s Severe allergic reactions might occur in some patients taking Trajenta 5 mg Tablet 10 s like anaphylaxis angioedema swelling under the skin and exfoliative skin conditions including Stevens Johnson syndrome Safety and efficacy of Trajenta 5 mg Tablet 10 s in children under 18 years have not been established so it should not be given to them Patients taking digoxin a heart medicine with Trajenta 5 mg Tablet 10 s should be closely monitored as severe drug interaction has been observed Trajenta 5 mg Tablet 10 s should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis